Cargando…

Safety and Efficacy of Sildenafil for Group 2 Pulmonary Hypertension in Left Heart Failure

Pulmonary hypertension (PH) is a multifactorial, progressive disease with poor outcomes. Group 2 PH is defined by pulmonary vascular disease with elevated pulmonary capillary wedge pressure including both left-sided obstructive lesions and diastolic heart failure (HF). Sildenafil was historically di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desai, Kinjal, Di Lorenzo, Michael, Zuckerman, Warren A., Emeruwa, Ezinne, Krishnan, Usha S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955063/ https://www.ncbi.nlm.nih.gov/pubmed/36832399 http://dx.doi.org/10.3390/children10020270

Ejemplares similares

Sildenafil in the treatment of pulmonary hypertension
por: Barnett, Christopher F, et al.
Publicado: (2006)

Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN)
por: Vijay Kumar, J.R., et al.
Publicado: (2021)

Sildenafil in pediatric pulmonary arterial hypertension
por: Dhariwal, AK, et al.
Publicado: (2015)

Safety and tolerability considerations in the use of sildenafil for children with pulmonary arterial hypertension
por: Dodgen, Andrew L, et al.
Publicado: (2015)

Efficacy and safety of oral sildenafil in children with Down syndrome and pulmonary hypertension
por: Beghetti, Maurice, et al.
Publicado: (2017)

Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease
por: Fraisse, Alain, et al.
Publicado: (2010)

Left ventricular heart failure and pulmonary hypertension(†)
por: Rosenkranz, Stephan, et al.
Publicado: (2016)

Efficacy of Beraprost Sodium Combined with Sildenafil and Its Effects on Vascular Endothelial Function and Inflammation in Patients Experiencing Left Heart Failure Complicated with Pulmonary Arterial Hypertension
por: Sun, Daoyuan, et al.
Publicado: (2021)

Pharmacokinetic and Pharmacodynamic Comparison of Sildenafil‐Bosentan and Sildenafil‐Ambrisentan Combination Therapies for Pulmonary Hypertension
por: Hakamata, A, et al.
Publicado: (2016)

Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant
por: Bonet, Luis Almenar, et al.
Publicado: (2014)

Is Sildenafil an Effective Therapy in the Management of Persistent Pulmonary Hypertension?
por: Yaseen, Hakam, et al.
Publicado: (2012)

Bosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension
por: Chinello, Pierangelo, et al.
Publicado: (2011)

Sildenafil in endotoxin-induced pulmonary hypertension: an experimental study
por: Kemper, Daniella Aparecida Godoi, et al.
Publicado: (2021)

Pulmonary arterial size and response to sildenafil in chronic thromboembolic pulmonary hypertension
por: Toshner, Mark R., et al.
Publicado: (2010)

Comparison of preventive effect of sildenafil and therapeutic effect of sildenafil treatment in rats with monocrotaline-induced pulmonary arterial hypertension
por: YOSHIYUKI, Rieko, et al.
Publicado: (2016)

Clinical deterioration after sildenafil cessation in patients with pulmonary hypertension
por: Keogh, Anne M, et al.
Publicado: (2008)

Simvastatin, Sildenafil and Their Combination in Monocrotaline Induced Pulmonary Arterial Hypertension
por: Lee, Dong Seok, et al.
Publicado: (2010)

Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
por: Ramani, Gautam V, et al.
Publicado: (2010)

Reported Sildenafil Side Effects in Pediatric Pulmonary Hypertension Patients
por: Siehr, Stephanie L., et al.
Publicado: (2015)

Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
por: Lilyasari, Oktavia, et al.
Publicado: (2019)

Sildenafil for bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis
por: van der Graaf, Marisa, et al.
Publicado: (2019)

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
por: Ghofrani, Hossein A., et al.
Publicado: (2006)

Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension
por: Tang, Yi, et al.
Publicado: (2022)

Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants
por: Schroeder, Lukas, et al.
Publicado: (2023)

Efficacy of Sildenafil in Infants with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension
por: Dillon, Kacie, et al.
Publicado: (2023)

Sildenafil and Kidney Function in Heart Failure with Preserved Ejection Fraction
por: Edmonston, Daniel, et al.
Publicado: (2023)

SILDENAFIL (VIAGRA) AND THE HEART
por: Chamsi-Pasha, Hassan
Publicado: (2001)

Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension
por: Verlinden, Nathan J., et al.
Publicado: (2020)

Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials
por: Awad, Ahmed K., et al.
Publicado: (2023)

Treatment of pulmonary hypertension with left heart disease: a concise review
por: Desai, Anish, et al.
Publicado: (2017)

Pulmonary function differences in patients with chronic right heart failure secondary to pulmonary arterial hypertension and chronic left heart failure
por: Liu, Wei-Hua, et al.
Publicado: (2014)

Current practices in the use of sildenafil for pulmonary arterial hypertension in Brazilian hospitals
por: de Souza, Ana HA, et al.
Publicado: (2009)

An opportunistic study evaluating pharmacokinetics of sildenafil for the treatment of pulmonary hypertension in infants
por: Thakkar, Nilay, et al.
Publicado: (2016)

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients
por: Duarte, Julio D., et al.
Publicado: (2018)

Pulmonary Hypertension in Heart Failure
por: Jang, Albert Youngwoo, et al.
Publicado: (2021)

Pulmonary hypertension in left heart disease
por: Mehra, Pratishtha, et al.
Publicado: (2017)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

The hypertensive effect of sorafenib is abolished by sildenafil
por: Dabiré, Hubert, et al.
Publicado: (2020)

Lower Doses of Bosentan in Combination With Sildenafil Might be Beneficial in Pulmonary Arterial Hypertension
por: Amin, Ahmad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7dnau5i65r39g44ha4b6hmh2oe